217 related articles for article (PubMed ID: 14529420)
21. Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
Kato Y; Onishi H; Machida Y
J Pharm Pharmacol; 2002 Apr; 54(4):529-37. PubMed ID: 11999131
[TBL] [Abstract][Full Text] [Related]
22. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
Kato Y; Onishi H; Machida Y
Int J Pharm; 2001 Sep; 226(1-2):93-106. PubMed ID: 11532574
[TBL] [Abstract][Full Text] [Related]
23. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
Bernkop-Schnürch A
Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
[TBL] [Abstract][Full Text] [Related]
24. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical application of biomedical polymers. XXIX. Preliminary study on film dosage form prepared from chitosan for oral drug delivery.
Miyazaki S; Yamaguchi H; Takada M; Hou WM; Takeichi Y; Yasubuchi H
Acta Pharm Nord; 1990; 2(6):401-6. PubMed ID: 2095798
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
Dini E; Alexandridou S; Kiparissides C
J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
[TBL] [Abstract][Full Text] [Related]
27. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
28. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
29. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
30. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Kitano M; Machida Y; Nagai T
Biol Pharm Bull; 1996 Feb; 19(2):241-5. PubMed ID: 8850315
[TBL] [Abstract][Full Text] [Related]
31. Ultrasonication of chitosan and chitosan nanoparticles.
Tang ES; Huang M; Lim LY
Int J Pharm; 2003 Oct; 265(1-2):103-14. PubMed ID: 14522123
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate loaded chitosan and chitin microspheres--in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma.
Singh UV; Udupa N
J Microencapsul; 1998; 15(5):581-94. PubMed ID: 9743914
[TBL] [Abstract][Full Text] [Related]
33. Controlled release of interleukin-2 from chitosan microspheres.
Ozbaş-Turan S; Akbuğa J; Aral C
J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
[TBL] [Abstract][Full Text] [Related]
34. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
Miyazaki T; Komuro T; Yomota C; Okada S
Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
[TBL] [Abstract][Full Text] [Related]
35. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.
Bal SM; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
Pharm Res; 2010 Sep; 27(9):1837-47. PubMed ID: 20559701
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride.
Snyman D; Hamman JH; Kotze AF
Drug Dev Ind Pharm; 2003 Jan; 29(1):61-9. PubMed ID: 12602493
[TBL] [Abstract][Full Text] [Related]
37. Chitosan microspheres as a potential carrier for drugs.
Sinha VR; Singla AK; Wadhawan S; Kaushik R; Kumria R; Bansal K; Dhawan S
Int J Pharm; 2004 Apr; 274(1-2):1-33. PubMed ID: 15072779
[TBL] [Abstract][Full Text] [Related]
38. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing.
Nafee NA; Ismail FA; Boraie NA; Mortada LM
Int J Pharm; 2003 Oct; 264(1-2):1-14. PubMed ID: 12972331
[TBL] [Abstract][Full Text] [Related]
39. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
40. Chitin and chitosan as direct compression excipients in pharmaceutical applications.
Badwan AA; Rashid I; Omari MM; Darras FH
Mar Drugs; 2015 Mar; 13(3):1519-47. PubMed ID: 25810109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
